Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

BIOMERICA, INC. (BMRA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

BIOMERICA, INC. (BMRA), most recent 12 months reported: revenue $4.34M, net loss $5.01M. Latest balance sheet on file: liquid cash $1.31M, total debt $500K, net cash $808K. From SEC filings. Others in In Vitro & In Vivo Diagnostic Substances: Alpha Teknova, Inc. · ImmuCell Corporation · Anbio Biotechnology · Aspira Women’s Health Inc. · VolitionRx Limited · Insight Molecular Diagnostics Inc. · Celldex Therapeutics, Inc. · Cardio Diagnostics Holdings, Inc.

Stock screener

Watchlist